Does racial concordance between HIV-positive patients and their physicians affect the time to receipt of protease inhibitors?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
BACKGROUND: Compared to whites, African Americans have been found to have greater morbidity and mortality from HIV, partly due to their lower use of effective antiretroviral therapy. Why racial disparities in antiretroviral use exist is not completely understood. We examined whether racial concordance (patients and providers having the same race) affects the time of receipt of protease inhibitors.
METHODS: We analyzed data from a prospective, cohort study of a national probability sample of 1,241 adults receiving HIV care with linked data from 287 providers. We examined the association between patient-provider racial concordance and time from when the Food and Drug Administration approved the first protease inhibitor to the time when patients first received a protease inhibitor.
RESULTS: In our unadjusted model, white patients received protease inhibitors much earlier than African-American patients (median 277 days compared to 439 days; P<.0001). Adjusting for patient characteristics only, African-American patients with white providers received protease inhibitors significantly later than African-American patients with African-American providers (median 461 days vs. 342 days respectively; P<.001) and white patients with white providers (median 461 vs. 353 days respectively; P=.002). In this model, no difference was found between African-American patients with African-American providers and white patients with white providers (342 vs. 353 days respectively; P>.20). Adjusting for patients’ trust in providers, as well as other patient and provider characteristics in subsequent models, did not account for these differences.
CONCLUSION: Patient-provider racial concordance was associated with time to receipt of protease inhibitor therapy for persons with HIV. Racial concordance should be addressed in programs, policies, and future racial and ethnic health disparity research.
- Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report. Vol. 13. Atlanta, Ga; 2001:1–44.
- Centers for Disease Control and Prevention. HIV/AIDS Surveillance Supplemental Report: Deaths Among Persons with AIDS Through December 2000. Atlanta, Ga; 2002:1–22.
- Asch, SM, Gifford, AL, Bozzette, SA (2001) Underuse of primary Mycobacterium avium complex and Pneumocystis carinii prophylaxis in the United States. J Acquir Immune Defic Syndr 28: pp. 340-4
- Bing, EG, Kilbourne, AM, Brooks, RA, Lazarus, EF, Senak, M (1999) Protease inhibitor use among a community sample of people with HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 20: pp. 474-80
- Crystal, S, Sambamoorthi, U, Moynihan, PJ, McSpiritt, E (2001) Initiation and continuation of newer antiretroviral treatments among Medicaid recipients with AIDS. J Gen Intern Med 16: pp. 850-9 CrossRef
- Cunningham, WE, Markson, LE, Andersen, RM (2000) Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the United States. HCSUS Consortium. HIV Cost and Services Utilization. J Acquir Immune Defic Syndr 25: pp. 115-23 CrossRef
- Jeffe, DB, Meredith, KL, Mundy, LM, Fraser, VJ (1998) Factors associated with HIV-infected patients’ recognition and use of HIV medications. J Acquir Immune Defic Syndr Hum Retrovirol 19: pp. 350-60
- Shapiro, MF, Morton, SC, McCaffrey, DF (1999) Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA 281: pp. 2305-15 CrossRef
- Stone, VE, Clarke, J, Lovell, J (1998) HIV/AIDS patients’ perspectives on adhering to regimens containing protease inhibitors. J Gen Intern Med 13: pp. 586-93 CrossRef
- Moore, RD, Stanton, D, Gopalan, R, Chaisson, RE (1994) Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med 330: pp. 763-8 CrossRef
- Palacio, H, Kahn, JG, Richards, TA, Morin, SF (2002) Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep 117: pp. 233-51
- Sambamoorthi, U, Moynihan, PJ, McSpiritt, E, Crystal, S (2001) Use of protease inhibitors and non-nucleoside reverse transcriptase inhibitors among Medicaid beneficiaries with AIDS. Am J Public Health 91: pp. 1474-81
- Andersen, R, Bozzette, S, Shapiro, M (2000) Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study. Health Serv Res 35: pp. 389-416
- Cooper-Patrick, L, Gallo, JJ, Gonzales, JJ (1999) Race, gender, and partnership in the patient-physician relationship. JAMA 282: pp. 583-9 CrossRef
- Laveist, TA, Nuru-Jeter, A (2002) Is doctor-patient race concordance associated with greater satisfaction with care?. J Health Soc Behav 43: pp. 296-306 CrossRef
- Murray-Garcia, JL, Selby, JV, Schmittdiel, J, Grumbach, K, Quesenberry, CP (2000) Racial and ethnic differences in a patient survey: patients’ values, ratings, and reports regarding physician primary care performance in a large health maintenance organization. Med Care 38: pp. 300-10 CrossRef
- Saha, S, Komaromy, M, Koepsell, TD, Bindman, ABRD (1999) Patient-physician racial concordance and the perceived quality and use of health care. Arch Intern Med 159: pp. 997-1004 CrossRef
- LaVeist, TA, Nuru-Jeter, A, Jones, KE (2003) The association of doctor-patient race concordance with health services utilization. J Public Health Policy 24: pp. 312-23 CrossRef
- Bozzette, SA, Berry, SH, Duan, N (1998) The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med 339: pp. 1897-904 CrossRef
- Frankel, MR, Shapiro, MF, Duan, N (1999) National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample. Health Serv Res 34: pp. 969-92
- Mathews, WC, McCutchan, JA, Asch, S (2000) National estimates of HIV-related symptom prevalence from the HIV Cost and Services Utilization Study. Med Care 38: pp. 750-62 CrossRef
- Rost, K, Burnam, MA, Smith, GR (1993) Development of screeners for depressive disorders and substance disorder history. Med Care 31: pp. 189-200 CrossRef
- Cunningham, WE, Andersen, RM, Katz, MH (1999) The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Med Care 37: pp. 1270-81 CrossRef
- Wilson, IB, Ding, L, Hays, RD, Shapiro, MF, Bozzette, SA, Cleary, PD (2002) HIV patients’ experiences with inpatient and outpatient care: results of a national survey. Med Care 40: pp. 1149-60 CrossRef
- Kao, AC, Green, DC, Davis, NA, Koplan, JP, Cleary, PD (1998) Patients’ trust in their physicians: effects of choice, continuity, and payment method. J Gen Intern Med 13: pp. 681-6 CrossRef
- Landon, BE, Wilson, IB, Wenger, NS (2002) Specialty training and specialization among physicians who treat HIV/AIDS in the United States. J Gen Intern Med 17: pp. 12-22 CrossRef
- Davison, AC, Hinkley, DV (1997) Bootstrap Methods and Their Application. Cambridge University Press, Cambridge, UK
- Easterbrook, PJ, Keruly, JC, Creagh-Kirk, T (1991) Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group. Jama 266: pp. 2713-18 CrossRef
- Lee, LM, Karon, JM, Selik, R, Neal, JJ, Fleming, PL (2001) Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984–1997. JAMA 285: pp. 1308-15 CrossRef
- LaVeist, TA, Carroll, T (2002) Race of physician and satisfaction with care among African-American patients. J Natl Med Assoc 94: pp. 937-43
- Chen, J, Rathore, SS, Radford, MJ, Wang, Y, Krumholz, HM (2001) Racial differences in the use of cardiac catheterization after acute myocardial infarction. N Engl J Med 344: pp. 1443-9 CrossRef
- Cooper, LA, Roter, DL, Johnson, RL, Ford, DE, Steinwachs, DM, Powe, NR (2003) Patient-centered communication, ratings of care, and concordance of patient and physician race. Ann Intern Med 139: pp. 907-15
- Ryn, M, Burke, J (2000) The effect of patient race and socio-economic status on physicians’ perceptions of patients. Soc Sci Med 50: pp. 813-28 CrossRef
- Bogart, LM, Catz, SL, Kelly, JA, Benotsch, EG (2001) Factors influencing physicians’ judgments of adherence and treatment decisions for patients with HIV disease. Med Decis Making 21: pp. 28-36
- Wong, MD, Cunningham, WE, Shapiro, MF (2004) Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients. J Gen Intern Med 19: pp. 366-74 CrossRef
- Korthuis, PT, Asch, S, Mancewicz, M (2002) Measuring medication: do interviews agree with medical record and pharmacy data?. Med Care 40: pp. 1270-82 CrossRef
- Stein, JH (2003) Dyslipidemia in the era of HIV protease inhibitors. Prog Cardiovasc Dis 45: pp. 293-304
- Ho, DD (1995) Time to hit HIV, early and hard. N Engl J Med 333: pp. 450-1 CrossRef
- Report of the NIH Panel to Define Principles of Therapy of HIV Infection. Ann Intern Med. 1998;128:1057–8.
- Carpenter, CC, Fischl, MA, Hammer, SM (1996) Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA 276: pp. 146-54 CrossRef
- Concorde Coordinating Committee. Lancet 343: pp. 871-81 CrossRef
- Volberding, PA, Lagakos, SW, Grimes, JM (1995) A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group. N Engl J Med 333: pp. 401-7 CrossRef
- Rabinowitz, HK, Diamond, JJ, Veloski, JJ, Gayle, JA (2000) The impact of multiple predictors on generalist physicians’ care of underserved populations. Am J Public Health 90: pp. 1225-8
- Carlisle, DM, Gardner, JE, Liu, H (1998) The entry of underrepresented minority students into U.S. medical schools: an evaluation of recent trends. Am J Public Health 88: pp. 1314-8
- Cohen, JJ (1997) Statistics don’t lie: anti-affirmative action is bad for our health. Acad Med 72: pp. 1084-1084 CrossRef
- DeVille, K (1999) Defending diversity: affirmative action and medical education. Am J Public Health 89: pp. 1256-61 CrossRef
- Does racial concordance between HIV-positive patients and their physicians affect the time to receipt of protease inhibitors?
Journal of General Internal Medicine
Volume 19, Issue 11 , pp 1146-1153
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- African Americans
- quality of health care
- physician-patient relations
- Industry Sectors
- Author Affiliations
- 1. the UCLA Robert Wood Johnson Clinical Scholars Program, School of Public Health, UCLA, Los Angeles, Calif
- 2. Division of General Internal Medicine and Health Services Research, School of Public Health, UCLA, Los Angeles, Calif
- 3. Department of Medicine, and Department of Health Services, School of Public Health, UCLA, Los Angeles, Calif
- 4. Department of Health Care Policy, Harvard Medical School, Boston, Mass